Skip to main content

Advertisement

Log in

Distinct clonal anomalies involving RUNX1 in acute myeloid leukemia at diagnosis and after bone marrow transplantation

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Ito Y (2004) Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 23:4198–4208

    Article  CAS  PubMed  Google Scholar 

  2. Michaud J, Scott HS, Escher R (2003) AML1 interconnected pathways of leukemogenesis. Cancer Invest 21:105–136

    Article  CAS  PubMed  Google Scholar 

  3. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321–330

    Article  CAS  PubMed  Google Scholar 

  4. De Braekeleer E, Ferec C, De Braekeleer M (2009) RUNX1 translocations in malignant hemopathies. Anticancer Res 29:1031–1038

    PubMed  Google Scholar 

  5. Christiansen DH, Andersen MK, Pedersen-Bjergaard J (2004) Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation. Blood 104:1474–1481

    Article  CAS  PubMed  Google Scholar 

  6. Osato M (2004) Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia. Oncogene 23:4284–4296

    Article  CAS  PubMed  Google Scholar 

  7. Niimi H, Harada H, Harada Y, Ding Y, Imagawa J, Inaba T, Kyo T, Kimura A (2006) Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations. Leukemia 20:635–644

    Article  CAS  PubMed  Google Scholar 

  8. Nucifora G, Birn DJ, Espinosa RI, Erickson P, Le Beau MM, Roulston D, McKeithan TW, Drabkin H, Rowley JD (1993) Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood 81:2728–2734

    CAS  PubMed  Google Scholar 

  9. Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle JN, Rowley JD (1994) Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Natl Acad Sci USA 91:4004–4008

    Article  CAS  PubMed  Google Scholar 

  10. De Braekeleer E, Douet-Guilbert N, Le Bris MJ, Morel F, De Braekeleer M (2007) 3;21 translocation, trisomy 8 and duplication of the Philadelphia chromosome: a rare, but recurrent, cytogenetic pathway in blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet 179:159–161

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc De Braekeleer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Braekeleer, E., Douet-Guilbert, N., Basinko, A. et al. Distinct clonal anomalies involving RUNX1 in acute myeloid leukemia at diagnosis and after bone marrow transplantation. Ann Hematol 89, 1277–1281 (2010). https://doi.org/10.1007/s00277-010-0937-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-010-0937-x

Keywords

Navigation